September
24
  2:53:04 AM

Discussing death with children should not be taboo

The UK lobby group GeneWatch claims that companies are preparing to market gene tests for a "susceptibility" to a disease and that this could frighten people into taking unnecessary medication. "Most claims that genes increase a person's risk of common conditions, such as heart disease, depression or obesity, later turn out to be wrong," says GeneWatch deputy director Dr Helen Wallace. "Unregulated genetic testing would mean that we could all be frightened into taking medicines for illness that we are never going to get." The UK does not require companies which market tests to confirm the link between a gene and a disease.

 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Best of the web

 Recent Posts
Neuroscience as the military’s new weapon
9 Feb 2012
Single-embryo transfers? Fugedaboudit, says NY IVF doctor
9 Feb 2012
Dutch celebrate a decade of euthanasia with a film festival
6 Feb 2012
Lost in surrogacy’s Bermuda Triangle
3 Feb 2012
Scores of UK patients die with bedsores, infections and malnutrition
3 Feb 2012

 Tags
Australia, organ donation, UK, informed consent, assisted suicide, IVF, euthanasia, US, stem cells, bioethics, Canada, commercialization, India, organ trafficking, human drama, neuroscience, suicide, clinical trials, law, HFEA, Down syndrome, genetic testing, sex selection, abortion, surrogacy, China, Netherlands, embryonic stem cells, research, sperm donation,